Juvic participated in the MIK Hot Spot (Made in Korea Online Exhibition) KHIDI and introduced its microneedle vaccine delivery platform with high hopes of meeting buyers and investors.
Juvic is developing a microneedle platform that delivers drugs into the epidermis without tissue damage or pain by supporting the drug on a microscopic structure that melts in the body. In particular, it is possible to effectively deliver drugs in the body while maintaining the activity of the drug through its own technology. Its microneedle platform is attracting attention for medical applications.
Vaccines are in dire need for a new drug delivery system due to limitations such as refrigerated distribution and medical waste. To overcome these limitations, Juvic created a vaccine formulation that does not require refrigeration by centrifugal molding and developed a disposable microneedle applicator. Among the reasons why the actual microneedle was not expanded for medical use, the drug activity was poor, and it was difficult to deliver the quantity accurately. However, Juvic has been able to maintain the drug's activity with its own technology, and has developed a new concept of applicator to provide a new era in vaccine distribution.
Based on these achievements, Juvic was selected by the government in November last year as a leading agency for a project to develop influenza vaccines into microneedle formulations. Professor Seong Baek-rin of Yonsei University, who is in charge of vaccine development in Juvic, has recently been elected as the head of the government's Vaccine Practical Technology Development Project, and is expected to provide a lot of support in developing new vaccine delivery technologies.
Juvic is a company specializing in the
development of medical microneedle established by Professor Jeong Hyung-il at
the Department of Biotechnology at Yonsei University. Professor Jeong has
already transferred the initial technology to RAPHAS that was listed on KOSDAQ
last year and successfully commercialized the microneedle business in the
cosmetics field. Professor Jeong and the research team is the largest and
highest level of microneedle development team in Korea.
Juvic is a company specializing in the development of medical microneedle established by Professor Jeong Hyung-il at the Department of Biotechnology at Yonsei University. Professor Jeong has already transferred the initial technology to RAPHAS that was listed on KOSDAQ last year and successfully commercialized the microneedle business in the cosmetics field. Professor Jeong and the research team is the largest and highest level of microneedle development team in Korea.
In emergency situations such as the recent
COVID-19 pandemic, there is a need for a non-face-to-face inoculation solution
that does not require refrigeration nor additional medical personnel, so the
new vaccine solution of Juvic is recognized as a very suitable form in
preparation for a national epidemic disaster.
Professor Jeong said, "Juvic's technology in formulation,
manufacturing, and delivery have been proven to be successful through the
implementation of government projects, and we are proceeding with government
support for the development of influenza vaccine formulations. We will do our
best to set up a platform to efficiently distribute the necessary vaccines in
the future so that the government can quickly supply the vaccines to the public
even in a disaster."
The products and services of the major
companies of KHIDI Health Industry Startup Innovation Center in the MIK Hot
Spot (Made in Korea Online Exhibition) will also be displayed in BIO KOREA
2020. Asia's biggest bio convention BIO KOREA 2020 co-organized by KHIDI and
Chungbuk Province and sponsored by MOHW will be open online due to the COVID-29
pandemic on May 18-23. Virtual exhibition halls, conference, and business
forums will be operated, and the companies will be promoting their
competitiveness. Also, with video meetings, businesses between overseas
speakers, buyers, and domestic and foreign participating companies will be
made. To date, more than 160 companies have applied for the virtual exhibition
booth at BIO KOREA 2020. Companies wishing to participate can apply through the
web page or email by Apr. 30.
The global news network AVING News has
begun holding the MIK Hot Spot (Made in Korea Online Exhibition) to help small
and medium-sized companies enter the market and attract investment 365 days a
year. AVING News has been running online exhibitions since 2005 and had 975
online exhibitions so far. Its YouTube online exhibition has placed itself as
Korea's largest online exhibition hall that opens with 19,000 videos (booths)
with more than 800,000 visits per month which means more than 10 million visits
The MIK Hot Spot online exhibition is
scheduled to be held regularly according to the field, target market, and
participating institutions, and it will be presented as a new type of online
business by transforming the know-hows and values of the participating
companies according to the trend. Companies that want to participate can apply
and apply through the marketing support projects from supporting institutions
in the local governments. Refer to the institutions for more information.